SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is drawing attention after a steep selloff alongside other AI infrastructure and neocloud stocks, amid concerns about financing needs, debt exposure and whether AI spending will generate adequate returns. Traders are divided between viewing the decline as an oversold buying opportunity with bounce or short-squeeze potential and warning that rebounds may fade as sector-wide selling continues.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras is drawing attention after extending its post-IPO slide to fresh lows, with traders citing upcoming share unlocks and insider selling, a TD Cowen price-target cut, and concerns about OpenAI concentration and the companys ability to scale. Bearish sentiment dominates, though some investors see the decline as overdone and point to its cash position, backlog, and wafer-scale AI technology as reasons to buy.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS CEO Angelos Stergious anniversary post about the companys next chapter with GPS and SLS009 has fueled speculation about upcoming clinical news or a buyout, though some traders see it as a routine reassurance. Discussion chiefly centers on the blinded Phase 3 REGAL trial, whose final analysis is triggered at 80 deaths; the last reported count was 78, and traders disagree on whether the prolonged wait is encouraging or simply leaves the outcome uncertain.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is drawing attention ahead of its Q3 earnings report, with traders weighing the results against scrutiny of the 6.2L engine recall fix after reports of failures following repairs. The community is debating whether potential warranty and legal costs could overshadow the quarter, while options positioning appears mixed.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJTs slide to fresh lows is being linked to Trumps declining approval and the approaching midterms, with traders treating the stock as highly exposed to political sentiment. Bearish discussion dominates, citing weak business fundamentals and Truth Social engagement, though some traders see the selloff as a buying opportunity.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

United CEO Scott Kirbys support for a wealth tax and inheritance taxes approaching 100% has prompted angry calls for a boycott, though some traders remain focused on the airlines upcoming quarterly results. Ahead of earnings, discussion also weighs bullish expectations against concerns that higher fuel costs and economic uncertainty could pressure margins.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is drawing attention amid a volatile rebound after a sharp AI and semiconductor selloff, as traders debate whether AI infrastructure demand can justify spending and valuations or whether debt and financing risksparticularly around CoreWeavesignal deeper trouble. Bulls cite continued demand and upcoming company updates, while skeptics point to weak price action and uncertain returns on AI capex.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

Deltas Q3 earnings miss and reduced full-year profit outlook, attributed to sharply higher fuel costs, dominate discussion despite resilient travel demand and premium revenue. Traders are divided between concern that fuel and other expenses will keep squeezing margins and optimism that strong bookings and fare increases can offset the pressure.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves steep selloff is drawing attention amid concerns about its heavy debt, costly financing and ability to fund AI infrastructure expansion, alongside a broader pullback in neocloud stocks. Bears warn of refinancing and dilution risks, while bulls point to contracted demand and Nvidia ties; traders also debate whether Goldmans Buy upgrade and ARKs purchases can support a recovery.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStops reminder that its warrants expire at a fixed exercise price has focused attention on whether shares can reach that threshold before the deadline. Traders disagree over whether Ryan Cohen will extend the warrants or provide a catalyst, while others expect them to expire worthless and view the resulting lack of dilution as favorable for common shareholders.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Novocures Optune Pax Receives Approval in Japan for the Treatment of Unresectable Locally Advanced Pancreatic Cancer

Novocure (Nasdaq: NVCR) announced today that Japans Ministry of Health, Labour and Welfare (MHLW) approved Optune Pax for the treatment of adult patients diagnosed with unresectable locally advanced pancreatic cancer, concomitant with gemcitabine and nab-paclitaxel. The approval of Optune Pax...

Novocure to Report Third Quarter 2026 Financial Results

Novocure (Nasdaq: NVCR) will report financial results for the third quarter 2026 on October 29, 2026, before the U.S. financial markets open. Novocure management will host a conference call and webcast at 8:00 a.m. EDT, October 29, to discuss the companys financial results for the three-month...

NeOnc Goes After Brain Cancer’s Holy Grail: Getting Drugs Where They’re Needed

As brain cancer research moves toward increasingly targeted and sophisticated treatment strategies, NeOnc Technologies Holdings (NASDAQ:NTHI) is emerging as a company focused on one of the field’s central challenges: how to deliver therapeutic agents more effectively to the brain and tumors while navigating the formidable barriers that have historically limited treatment options.

Novocure Reports Patient Data Exposure in Cybersecurity Incident

NVCR says a cyber incident exposed limited patient and contact data, but devices stayed secure and operations remained fully functional.

Novocure Announces Upcoming Investor Events

Novocure (NASDAQ: NVCR) announced today that management will participate in two upcoming investor events. Wells Fargo 21st Annual Healthcare Conference, September 9, 2026: Frank Leonard, Chief Executive Officer, will take part in a fireside chat at 10:15 a.m. ET, as well as one-on-one meetings with...

Wall Street Analysts See a 50.86% Upside in NovoCure (NVCR): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 50.9% in NovoCure (NVCR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Are You Looking for a Top Momentum Pick? Why NovoCure (NVCR) is a Great Choice

Does NovoCure (NVCR) have what it takes to be a top stock pick for momentum investors? Let's find out.

Wall Street Analysts Think NovoCure (NVCR) Could Surge 53.68%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 53.7% in NovoCure (NVCR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

4 Healthcare Stocks to Watch as Defensive Demand Strengthens

Healthcare's defensive demand is strengthening in 2026. BTSG, HRMY, UNH and NVCR stand out on improving earnings outlooks and steady sector momentum.

NovoCure (NVCR) Upgraded to Buy: What Does It Mean for the Stock?

NovoCure (NVCR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, the United Kingdom.

NovoCure Ltd

Why Did CSX, UNP, NVCR Stocks Surge To 52-Week Highs Today? 

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>RBC Capital increased CSX’s price target to $54, while JPMorgan lifted its target to $58.&nbsp;</li><li>Union Pacific shares hit a record high of $315.90 after the railroad company posted better-than-expected Q2 results.</li><li>Novocure’s Q2 adjusted EBITDA turned positive at $10.8 million compared with a loss a year earlier.&nbsp;</li></ul>CSX Corp. (CSX), Union Pacific Corp. (UNP), and Novocure (NVCR) hit fresh 52-week highs on Thursday after all three companies reported second-quarter (Q2) results that beat analyst expectations. The gains reflected strong demand in the rail sector and progress in Novocure’s medical technology business.&nbsp;CSX and Union Pacific stocks climbed 5% and 4%, respectively, while Novocure stock jumped 28%.&nbsp;<h2 class="st-heading-2">CSX Gains From Strong Rail Demand</h2><a href="https://stocktwits.com/symbol/CSX">CSX stock</a> hit a record high of $53.3 on Thursday on its second-quarter (Q2) earnings momentum, as its $3.94 billion revenue and $0.54 earnings per share surpassed the analysts’ consensus estimates of $3.8 billion and $0.52, respectively, according to Fiscal AI data.&nbsp;After CSX’s Q2 results, several Wall Street analysts raised their price targets for the stock. RBC Capital’s Walter Spracklin increased his target from $51 to $54 and kept an Outperform rating. JPMorgan’s Brian Ossenbeck also raised his target, moving it from $56 to $58, while maintaining an Overweight rating on the shares.Spracklin said CSX had another strong quarter, beating expectations and raising its outlook. He added that the latest results continue the company’s positive progress from earlier in the year and increase confidence in its future financial performance.RBC highlighted broad-based expansion across the business, with one of the strongest contributors coming from truck-to-rail conversions. On Stocktwits, retail sentiment around the stock remained in ‘bullish’ territory.&nbsp;<h2 class="st-heading-2">Union Pacific Delivers Broad-Based Improvement</h2><a href="https://stocktwits.com/symbol/UNP">Union Pacific stock</a> climbed to a record high of $315.90 after the company’s Q2 djusted earnings came in at $3.41 per share, above analysts’ forecast of $3.23, while revenue totaled $6.9 billion, helped by higher shipment volumes&nbsp;The company’s domestic intermodal business achieved another record quarter, helping drive a 21% increase in revenue from its premium freight segment. Following the earnings, Goldman Sachs raised its price target for Union Pacific to $317 from $297 while keeping a ‘Neutral’ rating.The firm said investors are likely to stay focused on Union Pacific's proposed acquisition of Norfolk Southern (NSC) rather than its improving business performance over the next several months. Retail sentiment around the stock improved to ‘extremely bullish’ from ‘bullish’ territory the previous day.&nbsp;<h2 class="st-heading-2">Novocure Reaches Profit Milestone</h2><a href="https://stocktwits.com/symbol/NVCR">Novocure stock</a> hit an annual high of $20.55 after after the company showed improvement in its financial performance. Q2 revenue increased 15.6% from the previous year to $183.6 million, while adjusted EBITDA turned into a $10.8 million profit compared with a loss during the same period last year.&nbsp;The biotechnology company credited expanding adoption of its Tumor Treating Fields products, including Optune Lua and Optune Pax, for supporting growth. Retail sentiment around the stock improved to ‘extremely bullish’ from ‘bullish’ territory the previous day.&nbsp;So far this year, UNP, NVCR and CSX stocks have gained between 31% and 54%.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nokia-s-massive-ai-orders-overshadow-soft-guidance-bofa-sees-upside/cZZYLRvR7Uu">Nokia's Massive AI Orders Overshadow Soft Guidance — BofA Sees 90% Upside</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A Union Pacific freight train travels on July 29, 2025 in Hutto, Texas.

CSX Corp. (CSX), Union Pacific Corp. (UNP), and Novocure (NVCR) hit fresh 52-week highs on Thursday after all three companies reported second-quarter (Q2) results that beat analyst expectations. The gains reflected strong demand in the rail sector and pro

Investors rewarded strong execution, improving profits and raised outlook.


CSX Corp.

Union Pacific Corp.

$SPCX

$NFLX

$TSLA

$META

Which earnings release are you most looking forward to this week: $SPCX, $NFLX, $TSLA, or $META? Drop a comment for others.

Current Price	$14.89
Prev Close	$14.07
Open	$14.14
Dividend Yield	0.00%
50-Day Moving Average	$16.33
Beta	1.49
Avg. Volume	1.09M
PE Ratio	-11.37

52-Week High	$21.45
52-Week Low	$9.82
Market Capitalization	$1.64B
EPS (Annual)	-$1.22
Price to Book	5.13
Revenue Per Employee	$408,319.63

Feed

News

Sentiment

Earnings

Fundamentals

Info

NVCR Fundamentals